Equistone taps Fund IV for 21st time with $100m Concept Life Sciences backing


biotech lab clinic researchUK-based buyout house Equistone Partners Europe has made its 21st deal from its €1.5bn Fund IV by investing $100m in newly-created lab business Concept Life Sciences to help it make three acquisitions.

Concept bought Peakdale Molecular, Resource & Environmental Consultants and Scientific Analysis Laboratories, which operate sites across the UK.

The group currently focuses on lab-based analytical testing and complex chemistry synthesis, with a view to accelerate investment in biological sciences, biostorage and stability testing.

Equistone said the deal was sourced by partner Steve O’Hare and Investment Director Andi Tomkinson, who both join the Concept board as non-executive directors.

O’Hare said, “We’ve worked closely with the management team to develop the new group, whilst simultaneously making the foundation acquisitions, which have given entry into high growth markets.

“The company has established a strong presence nationally and created a platform to target international growth and expand its service offering to existing clients.

“We look forward to developing the business further through the execution of its buy-and-build strategy.”

Copyright © 2014 AltAssets